Northeast Financial Consultants’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.79M | Hold |
6,419
| – | – | 0.07% | 114 |
|
|
2025
Q1 | $2M | Hold |
6,419
| – | – | 0.09% | 107 |
|
|
2024
Q4 | $1.67M | Hold |
6,419
| – | – | 0.07% | 116 |
|
|
2024
Q3 | $2.07M | Buy |
6,419
+33
| +0.5% | +$10.8K | 0.09% | 102 |
|
|
2024
Q2 | $2M | Sell |
6,386
-350
| -5% | -$103K | 0.09% | 99 |
|
|
2024
Q1 | $1.92M | Buy |
6,736
+650
| +11% | +$190K | 0.09% | 106 |
|
|
2023
Q4 | $1.75M | Hold |
6,086
| – | – | 0.1% | 107 |
|
|
2023
Q3 | $1.64M | Hold |
6,086
| – | – | 0.1% | 110 |
|
|
2023
Q2 | $1.35M | Hold |
6,086
| – | – | 0.08% | 117 |
|
|
2023
Q1 | $1.47M | Hold |
6,086
| – | – | 0.09% | 113 |
|
|
2022
Q4 | $1.6M | Buy |
6,086
+1,200
| +25% | +$322K | 0.11% | 108 |
|
|
2022
Q3 | $1.1M | Sell |
4,886
-1,200
| -20% | -$291K | 0.08% | 130 |
|
|
2022
Q2 | $1.48M | Sell |
6,086
-68
| -1% | -$16.7K | 0.1% | 113 |
|
|
2022
Q1 | $1.49M | Buy |
6,154
+68
| +1% | +$15.6K | 0.09% | 124 |
|
|
2021
Q4 | $1.37M | Sell |
6,086
-68
| -1% | -$14.4K | 0.08% | 127 |
|
|
2021
Q3 | $1.31M | Hold |
6,154
| – | – | 0.09% | 131 |
|
|
2021
Q2 | $1.5M | Hold |
6,154
| – | – | 0.1% | 124 |
|
|
2021
Q1 | $1.53M | Buy |
6,154
+68
| +1% | +$16.2K | 0.12% | 104 |
|
|
2020
Q4 | $1.4M | Hold |
6,086
| – | – | 0.12% | 108 |
|
|
2020
Q3 | $1.55M | Buy |
6,086
+177
| +3% | +$43.9K | 0.14% | 91 |
|
|
2020
Q2 | $1.39M | Hold |
5,909
| – | – | 0.13% | 92 |
|
|
2020
Q1 | $1.2M | Hold |
5,909
| – | – | 0.14% | 96 |
|
|
2019
Q4 | $1.42M | Hold |
5,909
| – | – | 0.13% | 100 |
|
|
2019
Q3 | $1.14M | Hold |
5,909
| – | – | 0.12% | 122 |
|
|
2019
Q2 | $1.09M | Hold |
5,909
| – | – | 0.11% | 121 |
|
|
2019
Q1 | $1.12M | Buy |
+5,909
| New | +$1.13M | 0.12% | 104 |
|
|
2018
Q4 | – | Sell |
-4,309
| Closed | -$893K | – | 161 |
|
|
2018
Q3 | $893K | Sell |
4,309
-417
| -9% | -$82.2K | 0.25% | 59 |
|
|
2018
Q2 | $872K | Hold |
4,726
| – | – | 0.27% | 55 |
|
|
2018
Q1 | $805K | Sell |
4,726
-111
| -2% | -$20.4K | 0.27% | 59 |
|
|
2017
Q4 | $841K | Buy |
4,837
+111
| +2% | +$19.6K | 0.28% | 56 |
|
|
2017
Q3 | $881K | Hold |
4,726
| – | – | 0.32% | 51 |
|
|
2017
Q2 | $814K | Hold |
4,726
| – | – | 0.32% | 57 |
|
|
2017
Q1 | $775K | Hold |
4,726
| – | – | 0.32% | 57 |
|
|
2016
Q4 | $691K | Hold |
4,726
| – | – | 0.31% | 61 |
|
|
2016
Q3 | $788K | Hold |
4,726
| – | – | 0.33% | 59 |
|
|
2016
Q2 | $719K | Buy |
4,726
+1,200
| +34% | +$187K | 0.32% | 54 |
|
|
2016
Q1 | $529K | Hold |
3,526
| – | – | 0.28% | 65 |
|
|
2015
Q4 | $572K | Hold |
3,526
| – | – | 0.3% | 63 |
|
|
2015
Q3 | $488K | Hold |
3,526
| – | – | 0.25% | 75 |
|
|
2015
Q2 | $541K | Hold |
3,526
| – | – | 0.24% | 77 |
|
|
2015
Q1 | $564K | Hold |
3,526
| – | – | 0.26% | 76 |
|
|
2014
Q4 | $562K | Hold |
3,526
| – | – | 0.3% | 70 |
|
|
2014
Q3 | $495K | Hold |
3,526
| – | – | 0.27% | 71 |
|
|
2014
Q2 | $417K | Sell |
3,526
-1,200
| -25% | -$139K | 0.24% | 73 |
|
|
2014
Q1 | $583K | Hold |
4,726
| – | – | 0.34% | 59 |
|
|
2013
Q4 | $539K | Buy |
+4,726
| New | +$538K | 0.36% | 53 |
|
Other funds holding AMGN
Northeast Financial Consultants's AMGN Position: Q2 2025 in Review
Northeast Financial Consultants held its Amgen (AMGN) position steady in Q2 2025 at 6,419 shares worth $1.79M. The position accounts for 0.07% of the portfolio, ranked #114.
Northeast Financial Consultants first reported a position in AMGN in Q4 2013 and has held it in 46 quarters since. The position peaked at $2.07M in Q3 2024. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.
- Northeast Financial Consultants held 6,419 shares of Amgen worth $1.79M as of Q2 2025.
- Northeast Financial Consultants left its Amgen share count unchanged in Q2 2025.
- Amgen made up 0.07% of Northeast Financial Consultants's portfolio in Q2 2025, its #114 holding.
- Northeast Financial Consultants first reported a position in Amgen in Q4 2013 and has held it in 46 quarters since.
- Northeast Financial Consultants's Amgen position peaked at $2.07M in Q3 2024.
- 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.
Based on Northeast Financial Consultants's 13F filing for Q2 2025, filed 15 Aug 2025.